Sfoglia per Autore
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals
2014-01-01 Strazzulla, A; Costa, C; Pisani, V; De Maria, V; Giancotti, F; Di Salvo, S; Parisi, Sg; Basso, M; Franzetti, Mm; Marascio, N; Barreca, Gs; Lamberti, Ag; Zicca, E; Postorino, Mc; Matera, G; Focà, A; Liberto, M; Torti, C
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy?
2014-01-01 Zicca, E; Marascio, N; Nucara, S; Fabiani, F; Strazzulla, A; Liberto, M; Focà, A; Torti, C; Perrotti, N; Trapasso, F; Quirino, A
Update on epidemiology of HCV in Italy: focus on the Calabria Region
2014-01-01 Marascio, N; Barreca, G; Zicca, E; Lamberti, A; Bianco, G; Matera, G; Surace, L; Berardelli, G; Surace, L; De Maria, V; Giancotti, F; Leone, R; Villella, V; Nisticò, S; Borelli, A; Caruso, V; Calderazzo, M; Griffo, G; Masciari, R; Minchella, P; Cosco, L; Laganà, C; Oliva, A; Foti, G; Fiorillo, M; Bocchiaro, G; Surace, P; Ciccaglione, A; Ciccozzi, M; Cesario, F; Focà, A.; Quirino, A; Liberto, M; Torti, C
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study
2014-01-01 Marascio, N; Ciccozzi, M; Equestre, M; Lo Presti, A; Costantino, A; Cella, E; Bruni, R; Pisani, G; Zicca, E; Barreca, Gs; Torti, C; Foca, A; Ciccaglione, Ar; Liberto, M
Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry
2014-01-01 Rametti, L; Puccio, R; Marascio, N; Catania, Mr; Focà, A; Matera, G; Liberto, M; Quirino A, Pulcrano G
Next Generation Sequencing and Microbiome Evaluation: Molecular Microbiology and Its Impact on Human Health
2015-01-01 Marascio, N.; Liberto, MARIA CARLA
Chapter: Next-generation sequencing and microbiome evaluation: Molecular microbiology and its impact on human health
2015-01-01 Focà, A; Liberto, Mc; Marascio, Nadia
Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome?
2015-01-01 Focà A, Liberto MC; Quirino, A; Marascio, N; Zicca, E; Pavia, G; Liberto, M
Virological Mechanisms in the Coinfection between HIV and HCV
2015-01-01 Liberto, M; Zicca, E; Pavia, G(; Marascio, N; Focà, A.; Torti, C; Quirino, A
RICONOSCIMENTO MOLECOLARE DEL DASABUVIR, TEGOBUVIR E SETROBUVIR NEL DOMINIO PALM I DELLA POLIMERASI DEL VIRUS DELL’EPATITE C, IN PRESENZA DELLA MUTAZIONE NATURALE 316N
2016-01-01 Marascio, N
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital
2016-01-01 Rizzo, C; Marascio, N; Zicca, E; Pavia, G; G Lamberti, A; Liberto, M; Focà, A; Quirino, A
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection?
2016-01-01 Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D’Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C.
Ultra-deep sequencing and bioinformatics approach to detect natural resistance-associated variants in DAA-naïve HCV positive patients
2016-01-01 Marascio, N; Pavia, G; Strazzulla, A; Dierckxc, T; Cuypers, L; Vranckenc, B; Barreca, Gs; Mirante, T; Malanga, D; Viglietto, G; Vandamme, Am; Torti, C; Liberto, Mc; Focà, A.
Structural analysis against HCV polymerase in presence of natural resistance-associated substitutions in HCV isolates from DAA-naïve patients
2016-01-01 Pavia, G; Marascio, N; Romeo, I; Talarico, C; Costa, G; Zicca, E; Barreca, Gs; Postorino, Mc; Mazzitelli, M; Torti, C; Artese, A; Alcaro, S; Liberto, Mc; Focà, A.
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants.
2016-01-01 Pavia, G; Marascio, N; Romeo, I; Talarico, C; Costa, G; Artese, A; Alcaro, S; Zicca, E; Barreca, Gs; Strazzulla, A; Torti, C; Liberto, Mc; Focà, A.
Founder effect of NS3 variant Q80K in HCV1a infected patients in Italy
2016-01-01 Cuypers, L; Fabeni, L; Marascio, N; Cento, V; Di Maio, Vc; Aragri, M; Pineda-Peña, Ac; Focà, A; Torti, C; Perno, Cf; Ceccherini-Silberstein, F; Vandamme, Am.
Virus-Free Synthesis of a Hepatitis C Virus p7 cDNA through a Three-Steps Polymerase Chain Reaction
2016-01-01 Zicca, E; Marascio, N; Pavia, G; Bombardiere, F; D’Agostino, S; Fabiani, F; Bilotta, A; Perrotti, N; Trapasso, F; Alfredo, Focà; Liberto, M
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection?
2016-01-01 Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D’Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C.
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients
2016-01-01 Marascio, Nadia; Grazia, Pavia1; Alessio, Strazzulla; Tim, Dierckx; Lize, Cuypers; Bram, Vrancken; Giorgio Settimo Barreca, ; Teresa, Mirante; Malanga, D; Duarte Mendes Oliveira, ; Anne-Mieke, Vandamme; Torti, C; Liberto, M; Focà, A; The Sinergie-Umg Study, Group.
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?
2016-01-01 Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D'Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals | 1-gen-2014 | Strazzulla, A; Costa, C; Pisani, V; De Maria, V; Giancotti, F; Di Salvo, S; Parisi, Sg; Basso, M; Franzetti, Mm; Marascio, N; Barreca, Gs; Lamberti, Ag; Zicca, E; Postorino, Mc; Matera, G; Focà, A; Liberto, M; Torti, C | |
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy? | 1-gen-2014 | Zicca, E; Marascio, N; Nucara, S; Fabiani, F; Strazzulla, A; Liberto, M; Focà, A; Torti, C; Perrotti, N; Trapasso, F; Quirino, A | |
Update on epidemiology of HCV in Italy: focus on the Calabria Region | 1-gen-2014 | Marascio, N; Barreca, G; Zicca, E; Lamberti, A; Bianco, G; Matera, G; Surace, L; Berardelli, G; Surace, L; De Maria, V; Giancotti, F; Leone, R; Villella, V; Nisticò, S; Borelli, A; Caruso, V; Calderazzo, M; Griffo, G; Masciari, R; Minchella, P; Cosco, L; Laganà, C; Oliva, A; Foti, G; Fiorillo, M; Bocchiaro, G; Surace, P; Ciccaglione, A; Ciccozzi, M; Cesario, F; Focà, A.; Quirino, A; Liberto, M; Torti, C | |
Back to the origin of HCV 2c subtype and spreading to the Calabria region (Southern Italy) over the last two centuries: A phylogenetic study | 1-gen-2014 | Marascio, N; Ciccozzi, M; Equestre, M; Lo Presti, A; Costantino, A; Cella, E; Bruni, R; Pisani, G; Zicca, E; Barreca, Gs; Torti, C; Foca, A; Ciccaglione, Ar; Liberto, M | |
Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry | 1-gen-2014 | Rametti, L; Puccio, R; Marascio, N; Catania, Mr; Focà, A; Matera, G; Liberto, M; Quirino A, Pulcrano G | |
Next Generation Sequencing and Microbiome Evaluation: Molecular Microbiology and Its Impact on Human Health | 1-gen-2015 | Marascio, N.; Liberto, MARIA CARLA | |
Chapter: Next-generation sequencing and microbiome evaluation: Molecular microbiology and its impact on human health | 1-gen-2015 | Focà, A; Liberto, Mc; Marascio, Nadia | |
Gut Inflammation and Immunity: What Is the Role of the Human Gut Virome? | 1-gen-2015 | Focà A, Liberto MC; Quirino, A; Marascio, N; Zicca, E; Pavia, G; Liberto, M | |
Virological Mechanisms in the Coinfection between HIV and HCV | 1-gen-2015 | Liberto, M; Zicca, E; Pavia, G(; Marascio, N; Focà, A.; Torti, C; Quirino, A | |
RICONOSCIMENTO MOLECOLARE DEL DASABUVIR, TEGOBUVIR E SETROBUVIR NEL DOMINIO PALM I DELLA POLIMERASI DEL VIRUS DELL’EPATITE C, IN PRESENZA DELLA MUTAZIONE NATURALE 316N | 1-gen-2016 | Marascio, N | |
Efflux Pump AdeABC Assessment in Acinetobacter baumannii Strains Isolated in a Teaching Hospital | 1-gen-2016 | Rizzo, C; Marascio, N; Zicca, E; Pavia, G; G Lamberti, A; Liberto, M; Focà, A; Quirino, A | |
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection? | 1-gen-2016 | Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D’Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C. | |
Ultra-deep sequencing and bioinformatics approach to detect natural resistance-associated variants in DAA-naïve HCV positive patients | 1-gen-2016 | Marascio, N; Pavia, G; Strazzulla, A; Dierckxc, T; Cuypers, L; Vranckenc, B; Barreca, Gs; Mirante, T; Malanga, D; Viglietto, G; Vandamme, Am; Torti, C; Liberto, Mc; Focà, A. | |
Structural analysis against HCV polymerase in presence of natural resistance-associated substitutions in HCV isolates from DAA-naïve patients | 1-gen-2016 | Pavia, G; Marascio, N; Romeo, I; Talarico, C; Costa, G; Zicca, E; Barreca, Gs; Postorino, Mc; Mazzitelli, M; Torti, C; Artese, A; Alcaro, S; Liberto, Mc; Focà, A. | |
Molecular recognition studies of dasabuvir, tegobuvir, and setrobuvir against natural Hepatitis C Virus NS5B polymerase variants. | 1-gen-2016 | Pavia, G; Marascio, N; Romeo, I; Talarico, C; Costa, G; Artese, A; Alcaro, S; Zicca, E; Barreca, Gs; Strazzulla, A; Torti, C; Liberto, Mc; Focà, A. | |
Founder effect of NS3 variant Q80K in HCV1a infected patients in Italy | 1-gen-2016 | Cuypers, L; Fabeni, L; Marascio, N; Cento, V; Di Maio, Vc; Aragri, M; Pineda-Peña, Ac; Focà, A; Torti, C; Perno, Cf; Ceccherini-Silberstein, F; Vandamme, Am. | |
Virus-Free Synthesis of a Hepatitis C Virus p7 cDNA through a Three-Steps Polymerase Chain Reaction | 1-gen-2016 | Zicca, E; Marascio, N; Pavia, G; Bombardiere, F; D’Agostino, S; Fabiani, F; Bilotta, A; Perrotti, N; Trapasso, F; Alfredo, Focà; Liberto, M | |
Is neutrophil gelatinase associated lipocalin a marker of renal impairment in HCV infection? | 1-gen-2016 | Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D’Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C. | |
Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naïve Patients | 1-gen-2016 | Marascio, Nadia; Grazia, Pavia1; Alessio, Strazzulla; Tim, Dierckx; Lize, Cuypers; Bram, Vrancken; Giorgio Settimo Barreca, ; Teresa, Mirante; Malanga, D; Duarte Mendes Oliveira, ; Anne-Mieke, Vandamme; Torti, C; Liberto, M; Focà, A; The Sinergie-Umg Study, Group. | |
Is neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection? | 1-gen-2016 | Strazzulla, A; Coppolino, G; Di Fatta, C; Giancotti, F; D'Onofrio, G; Postorino, Mc; Mazzitelli, M; Mammone, Sv; Gentile, I; Rivoli, L; Palella, E; Gravina, T; Costa, C; Pisani, V; De Maria, V; Barreca, Gs; Marascio, N; Focà, A; Fuiano, G; Gulletta, E; Torti, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile